© Globe Newswire
18.02.2025
KDEV
LISTED
STO
Karolinska Developments portfolio company Promimic publishes positive results on reduction of bacteria growth on HAnano Surface
News Preview
STOCKHOLM, SWEDEN, February 18 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Promimic has published positive results showing a reduction of bacterial growth on the company’s implant surface HAnano Surface. The results are published in the Journal of Functional Biomaterials....
Themefolio
Profiler
Peergroup
© PR Newswire
18.02.2025
BIOA B
LISTED
STO
Leqembi® sales reaches €200 million - first sales milestone achieved
News Preview
STOCKHOLM, Feb. 18, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai has notified BioArctic that the first sales milestone according to the licensing agreement has been reached. The milestone was reached as sales of Leqembi reached €200 million in Eisai fiscal year 2024 (April 2024 - Match 2025). The event entit...
Themefolio
Profiler
Peergroup
© PR Newswire
18.02.2025
BIOA B
LISTED
STO
Leqembi® sales reaches €200 million - first sales milestone achieved
News Preview
STOCKHOLM, Feb. 18, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai has notified BioArctic that the first sales milestone according to the licensing agreement has been reached. The milestone was reached as sales of Leqembi reached €200 million in Eisai fiscal year 2024 (April 2024 - Match 2025). The event entit...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
17.02.2025
GLPG
LISTED
EURONEXT
Galapagos receives transparency notification and 13D filing from Tang Capital
News Preview
Mechelen, Belgium; February 17, 2025, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification and 13D filing from Tang Capital. ...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
17.02.2025
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE – MAJOR SHAREHOLDER ANNOUNCEMENTS17 FEBRUARY 2025 at 15.15 EET...
Themefolio
Profiler
Peergroup
© BusinessWire
17.02.2025
ICLR
LISTED
NASDAQ
ICLR INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against ICON PLC and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit
News Preview
Robbins Geller Rudman & Dowd LLP announces that purchasers of ICON PLC (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024, both dates inclusive (the “Class Period”), have until April 11, 2025 to seek appointment as lead plaintiff of the ICON class action lawsuit. Captioned Shing v. ICON plc, No. 25-cv-00763 (E.D.N.Y.), t...
Themefolio
Profiler
Peergroup
© EQS Newswire
17.02.2025
DIM
LISTED
EURONEXT
Sartorius Stedim Biotech releases Universal Registration Document 2024
News Preview
Sartorius Stedim Biotech SA
/ Key word(s): Annual Results
Sartorius Stedim Biotech releases Universal Registration Document 2024 17-Feb-2025 / 10:02 CET/CEST
Aubagne, France | February 17, 2025
Sartorius Stedim Biotech releases Universal Registration Document 2024Sartorius Stedim Biotech, a leading partner of the biopharma ind......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.02.2025
SRT3
LISTED
XETR
Sartorius releases Annual Report for 2024
News Preview
Göttingen, Germany | February 17, 2025
Sartorius releases Annual Report for 2024
The life science group Sartorius today released its Annual Report for 2024. The document is available at the following link: https://ir-reports.sartorius.com/en/ag/fy-2024/
Financial calendar
March 27, 2025 Annual Shareholders’ Meeting
April 16, 2025......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.02.2025
SRT3
LISTED
XETR
Sartorius veröffentlicht Geschäftsbericht für 2024
News Preview
Göttingen, 17. Februar 2025
Sartorius veröffentlicht Geschäftsbericht für 2024
Der Life-Science-Konzern Sartorius hat heute seinen Geschäftsbericht für 2024 veröffentlicht. Das Dokument ist unter folgendem Link verfügbar: https://ir-reports.sartorius.com/de/ag/fy-2024/
Nächste Termine
27. März 2025 Hauptversammlung
16. Apri......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.02.2025
FYB
LISTED
XETR
Formycon AG informs about recent developments in various biosimilar projects and invites to conference call
News Preview
Press Release // February 17, 2025
Formycon AG informs about recent developments in various biosimilar projects and invites to conference call
Formycon continues FYB206 development without Phase III trial and thus takes pioneering role among pembrolizumab biosimilar developers; investment savings expected to amount to a high double-digit millio......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.02.2025
FYB
LISTED
XETR
Formycon AG informiert über jüngste Entwicklungen in verschiedenen Biosimilar-Projekten und lädt zur Telefonkonferenz ein
News Preview
Pressemitteilung // 17. Februar 2025
Formycon AG informiert über jüngste Entwicklungen in verschiedenen Biosimilar-Projekten und lädt zur Telefonkonferenz ein
Formycon setzt FYB206-Entwicklung ohne Phase-III-Studie fort und nimmt damit Vorreiterrolle unter Pembrolizumab-Biosimilar-Entwicklern ein; Investitionsersparnisse belaufen sich voraussic......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.02.2025
FYB
LISTED
XETR
Formycon announces decision on Phase III trial with FYB206 and provides update on potential need to adjust the valuation of FYB202 and FYB201
News Preview
Disclosure of inside information according to Article 17 of the Regulation (EU) No 596/2014
Formycon announces decision on Phase III trial with FYB206 and provides update on potential need to adjust the valuation of FYB202 and FYB201
Formycon terminates Phase III study ("Lotus") for FYB206 following positive feedback from the U.S. Food and Drug A......
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© EQS Newswire
17.02.2025
FYB
LISTED
XETR
Formycon gibt Entscheidung zu Phase-III-Studie von FYB206 bekannt und informiert über potenziellen Anpassungsbedarf bei der Bewertung von FYB202 und FYB201
News Preview
Veröffentlichung von Insiderinformationen nach Artikel 17 der Verordnung (EU) Nr. 596/2014
Formycon gibt Entscheidung zu Phase-III-Studie von FYB206 bekannt und informiert über potenziellen Anpassungsbedarf bei der Bewertung von FYB202 und FYB201
Formycon stellt Phase-III-Studie (Lotus) für FYB206 nach positivem Feedback der U.S. Food and Drug Ad......
Themefolio
Profiler
Peergroup
© Globe Newswire
17.02.2025
GN
LISTED
CPH
GN Store Nord A/S - Notice to convene the Annual General Meeting 2025
News Preview
GN Store Nord’s Annual General Meeting will be held on Wednesday, March 12, 2025, at 10:00 a.m. CET at the company’s address: Lautrupbjerg 7, 2750 Ballerup, Denmark....
Themefolio
Profiler
Peergroup
© Globe Newswire
16.02.2025
SN
LISTED
LSE
Smith+Nephew steps forward with innovative Sports Medicine foot & ankle repair solutions in Australia and New Zealand
News Preview
First in market to offer Adjustable Tensioning Technology* for insertional Achilles reconstruction and lateral ankle instability repair...
Themefolio
Profiler
Peergroup
© BusinessWire
16.02.2025
ICLR
LISTED
NASDAQ
ICLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ICON PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ICON PLC (“ICON” or “the Company”) (NASDAQ: ICLR) and certain of its officers.
Class Definition
This lawsuit seeks to recover damages against Defendants for alleged violations of...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.02.2025
BAVA
LISTED
CPH
Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and Older
News Preview
COPENHAGEN, Denmark, February 14, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that the U.S. Food and Drug Administration (FDA) has approved VIMKUNYA™ (Chikungunya Vaccine, Recombinant) for injection, the first virus-like particle (VLP) single-dose chikungunya vaccine in the U.S. for persons 12 years of age and older....
Themefolio
Profiler
Peergroup
© Globe Newswire
14.02.2025
GNFT
LISTED
EURONEXT
GENFIT Announces the Amendment of the Final Terms of the Dual Proposal to the 2025 OCEANEs Holders
News Preview
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), February 14, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the amendment of the final terms of the 2025 OCEANEs repurchase proposal and t...
Themefolio
Profiler
Peergroup
© BusinessWire
14.02.2025
ICLR
LISTED
NASDAQ
Kessler Topaz Meltzer & Check, LLP Class Action Announcement ICLR: A Securities Fraud Class Action Lawsuit Was Filed Against ICON Public Limited Company (ICLR)
News Preview
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against ICON Public Limited Company (“ICON”) (NASDAQ: ICLR) on behalf of all purchasers of ICON ordinary shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”). The lead plaintiff...
Themefolio
Profiler
Peergroup
© ActuNews
14.02.2025
OXUR
LISTED
EURONEXT
Oxurion versterkt zijn Raad van Bestuur met de komst van Nelly Souleymane
News Preview
LEUVEN, BELGIË - 14 februari 2024 – 19u00 CET - Oxurion NV (Euronext Brussels: OXUR), een biofarmaceutisch bedrijf met hoofdzetel in Leuven, kondigt een wijziging aan in haar Raad van Bestuur met het vertrek van mevrouw Anat Loewenstein en mevrouw Nathalie Laarakker, met ingang vanaf 13 januari 2025, en de cooptatie door de Raad van...
Themefolio
Profiler
Peergroup
© ActuNews
14.02.2025
OXUR
LISTED
EURONEXT
Oxurion renforce son Conseil d'Administration avec l'arrivée de Nelly Souleymane
News Preview
Louvain, BELGIQUE – 14 février 2024 – 19h00, Oxurion NV (Euronext Bruxelles : OXUR), entreprise biopharmaceutique basée à Louvain, annonce une évolution de son Conseil d'Administration avec le départ de Mme Anat Loewenstein et Mme Nathalie Laarakker, effectif depuis le 13 janvier 2025, et l'int...
Themefolio
Profiler
Peergroup
© ActuNews
14.02.2025
OXUR
LISTED
EURONEXT
Oxurion strengthens its Board of Directors with the arrival of Nelly Souleymane
News Preview
LEUVEN, BELGIUM - February 14, 2024 - 7:00PM, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announces a change in its Board of Directors with the departure of Ms. Anat Loewenstein and Ms. Nathalie Laarakker, effective as of January 13, 2025, and the integration of Nelly Souleymane as an indepen...
Themefolio
Profiler
Peergroup
© BusinessWire
14.02.2025
ICLR
LISTED
NASDAQ
Deadline Alert: ICON plc (ICLR) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
News Preview
Glancy Prongay & Murray LLP reminds investors of the upcoming April 11, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired ICON plc (“ICON” or the “Company”) (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”)....
Themefolio
Profiler
Peergroup
© PR Newswire
14.02.2025
RAY B
LISTED
STO
Invitation to presentation of RaySearch's Year-end report 2024
News Preview
STOCKHOLM, Feb. 14, 2025 /PRNewswire/ -- Analysts, investors, and the media are invited to a presentation of RaySearch's Year-end report 2024 on February 21, 2025, at 10.00 am CET. The report will be published on February 21, 2025, at 07.45 am and will be available together with presentation slides on raysearchlabs.com. Johan Löf, founder and CEO...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.02.2025
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE – MAJOR SHAREHOLDER ANNOUNCEMENTS14 FEBRUARY 2025 at 16.15 EET...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.02.2025
ORY
LISTED
BME
ORYZON Announces Journal Publication of Final Phase IIa REIMAGINE Results with Vafidemstat in Psychiatry and Clinical Neurosciences
News Preview
MADRID and CAMBRIDGE, Mass., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that the final results of the Phase IIa REIMAGINE study, which evaluated the safety...
Themefolio
Profiler
Peergroup
© PR Newswire
14.02.2025
ICLR
LISTED
NASDAQ
Contact Levi & Korsinsky by April 11, 2025 Deadline to Join Class Action Against ICON Public Limited Company(ICLR)
News Preview
NEW YORK, Feb. 14, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in ICON Public Limited Company ("ICON " or the "Company") (NASDAQ: ICLR) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seek...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.02.2025
GN
LISTED
CPH
New share-based incentive program for members of management and certain key employees
News Preview
With reference to GN's Remuneration Policy which was approved at the annual general meeting on March 13, 2024 and pursuant to which the long-term incentive program from 2025 onward will be based on performance share units (PSUs) to support performance, retention, and alignment of interest with the company’s shareholders, the Board of Directors of G...
Themefolio
Profiler
Peergroup
© BusinessWire
13.02.2025
EHAB
LISTED
NYSE
Enhabit Home Health & Hospice Announces Date of 2024 Fourth Quarter Earnings Call
News Preview
Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the fourth quarter ended Dec. 31, 2024, on March 5, 2025, and host a webcast and conference call on March 6, 2025. Individuals who would like to participate in the conference call webcast should join 15 minutes before the...
Themefolio
Profiler
Peergroup
© BusinessWire
13.02.2025
QGEN
LISTED
NYSE
QIAGEN Strengthens Global Bioinformatics Leadership With New Data Center in Australia/Asia-Pacific Region
News Preview
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the official opening of a new data center in Melbourne, Australia, designed to strengthen its global bioinformatics leadership position in this region of the world.
This latest addition reflects QIAGEN’s ongoing commitment to enhance its bioinformatics data infrastructure, enabli...
Themefolio
Profiler
Peergroup
© BusinessWire
13.02.2025
ICLR
LISTED
NASDAQ
Deadline Approaching: ICON plc (ICLR) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming April 11, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased ICON plc (“ICON” or the “Company”) (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”).
IF YOU ARE AN INVESTOR WHO SU...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.02.2025
ZEAL
LISTED
CPH
Zealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial results
News Preview
Press Release – No. 3 / 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
13.02.2025
ICLR
LISTED
NASDAQ
ICON INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against ICON PLC and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit
News Preview
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of ICON PLC (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024, both dates inclusive (the “Class Period”), have until April 11, 2025 to seek appointment as lead plaintiff of the ICON class action lawsuit. Captioned Shing v. ICON plc, No. 25-cv-007...
Themefolio
Profiler
Peergroup
© BusinessWire
13.02.2025
TEM
LISTED
NASDAQ
Tempus Announces Collaboration with IFLI Aimed at Supporting Development of Targeted Therapies for Follicular Lymphoma
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a new collaboration with the Institute for Follicular Lymphoma Innovation (IFLI), a global, non-profit, private foundation dedicated to accelerating the development of innovative treatment options for patie...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.02.2025
GMAB
LISTED
CPH
Notice to Convene the Annual General Meeting of Genmab A/S
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© EQS Newswire
13.02.2025
EUZ
LISTED
XETR
Eckert & Ziegler Affected by Cyber Attack
News Preview
Berlin, 13 February 2025. Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) has suffered a cyber attack on parts of its IT systems. The systems were temporarily shut down proactively and disconnected from the internet to minimise any potential impact. The IT systems and the effects of the attack are currently being examined. The utmost care is be......
Themefolio
Profiler
Peergroup
© EQS Newswire
13.02.2025
EUZ
LISTED
XETR
Eckert & Ziegler von Cyberangriff betroffen
News Preview
Berlin, 13. Februar 2025. Bei der Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) hat es einen Cyberangriff auf Teile ihrer IT-Systeme gegeben. Die Systeme wurden vorübergehend proaktiv heruntergefahren und vom Internet getrennt, um potenzielle Auswirkungen zu minimieren. Die IT-Systeme sowie die Auswirkungen des Angriffs werden aktuell geprüft......
Themefolio
Profiler
Peergroup
© EQS Newswire
13.02.2025
1SXP
LISTED
XETR
SCHOTT Pharma records good start into fiscal year and confirms full year outlook
News Preview
SCHOTT Pharma records good start into fiscal year and confirms full year outlook
Q1 2025 revenues reached EUR 230m; decrease of 1% yoy as reported or increase of 4% at constant currencies
Q1 2025 EBITDA margin of 25.1% as reported or 26.3% at constant currencies
Share of strong-margin high-value solutions (HVS) further increased to 55%
Busines......
Themefolio
Profiler
Peergroup
© EQS Newswire
13.02.2025
1SXP
LISTED
XETR
SCHOTT Pharma startet gut ins neue Geschäftsjahr und bestätigt Prognose für 2025
News Preview
SCHOTT Pharma startet gut ins neue Geschäftsjahr und bestätigt Prognose für 2025
Q1 2025: Umsatz von 230 Mio. Euro; berichteter Rückgang von 1 %, währungsbereinigtes Umsatzwachstum von 4 % gegenüber dem Vorjahr
Q1 2025: EBITDA-Marge von 25,1 % berichtet, und 26,3 % währungsbereinigt
Anteil der margenstarken High-Value-Lösungen (HVS) weiter auf ......
Themefolio
Profiler
Peergroup
© Globe Newswire
13.02.2025
ATAI
LISTED
NASDAQ
atai Life Sciences Announces Pricing of Public Offering of Common Shares
News Preview
NEW YORK and BERLIN, Feb. 12, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company focused on transforming the treatment of mental health disorders, today announced the pricing of a registered underwritten offering of 26,190,477 common shares, at a price of $2.10 per share. a...
Themefolio
Profiler
Peergroup
© BusinessWire
12.02.2025
ICLR
LISTED
NASDAQ
Law Offices of Frank R. Cruz Encourages ICON plc (ICLR) Investors To Inquire About Securities Fraud Class Action
News Preview
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased ICON plc (“ICON” or the “Company”) (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”). ICON investors have until April 11, 2025 to file a lead plaintiff motion.
IF YOU S...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.02.2025
ASND
LISTED
NASDAQ
Ascendis Pharma Reports Fourth Quarter and Full Year 2024 Financial Results
News Preview
– Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.02.2025
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE – MAJOR SHAREHOLDER ANNOUNCEMENTS12 FEBRUARY 2025 at 21.00 EET ...
Themefolio
Profiler
Peergroup
© BusinessWire
12.02.2025
ICLR
LISTED
NASDAQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Encourages ICON plc (ICLR) Investors to Inquire About Securities Fraud Class Action
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired ICON plc (“ICON” or the “Company”) (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”...
Themefolio
Profiler
Peergroup
© BusinessWire
12.02.2025
ICLR
LISTED
NASDAQ
ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company (“Icon” or “the Company”) (NASDAQ: ICLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission....
Themefolio
Profiler
Peergroup
© Globe Newswire
12.02.2025
GMAB
LISTED
CPH
Genmab Files Annual Report with the U.S. Securities and Exchange Commission
News Preview
Media ReleaseCOPENHAGEN, Denmark; February 12, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.02.2025
GMAB
LISTED
CPH
Genmab Publishes 2024 Annual Report
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.02.2025
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals to Release Fourth-Quarter and Full-Year 2024 Financial Results and Host Webcast on February 26, 2025
News Preview
CONSHOHOCKEN, Pa., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that it will release its fourth-quarter and full-year 2024 financial results on Wednesday, Feb. 26, 2025, prior to the open of the U.S. financial markets....
Themefolio
Profiler
Peergroup
© PR Newswire
12.02.2025
INDV
LISTED
NASDAQ
Indivior Statement RE: Delayed FDA Approval of SUBLOCADE® Label Changes
News Preview
RICHMOND, Va., Feb. 12, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) provides the following update regarding its PDUFA action date for label changes (rapid initiation protocol and alternative injection sites) for SUBLOCADE® (buprenorphine extended-release) Injection, which was scheduled for February 7, 2025:...
Themefolio
Profiler
Peergroup
© Newsfile
12.02.2025
COPN
LISTED
SIX
Cosmo to Host Investor Day on April 9, 2025
News Preview
Dublin, Ireland--(Newsfile Corp. - February 12, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) is pleased to announce that it will host an Investor Day on Wednesday, April 9, 2025. The live event will be held at the Hotel “Park Hyatt” at Beethovenstrasse 21 in 8002 Zurich, S...
Themefolio
Profiler
Peergroup
© EQS Newswire
12.02.2025
AFX
LISTED
XETR
Carl Zeiss Meditec erzielt leichtes Umsatzwachstum im ersten Quartal 2024/25
News Preview
Carl Zeiss Meditec erzielt leichtes Umsatzwachstum im ersten Quartal 2024/25
Auftragseingang und Auftragsbestand deutlich erholt
JENA, 12. Februar 2025
Carl Zeiss Meditec erzielte im ersten Quartal des Geschäftsjahres 2024/25 aufgrund der DORC-Akquisition einen Umsatz von rund 490,5 Millionen Euro (Vj. 475,0 Millionen Euro), ein Wachstum v......
Themefolio
Profiler
Peergroup
© EQS Newswire
12.02.2025
AFX
LISTED
XETR
Carl Zeiss Meditec achieves slight revenue growth in first three months of 2024/25
News Preview
Carl Zeiss Meditec achieves slight revenue growth in first three months of 2024/25
Significant recovery in order entry and order backlog
JENA, 12 February 2025
Carl Zeiss Meditec generated revenue of €490.5m in the first three months of fiscal year 2024/25 (prior year: €475.0m), corresponding to growth of +3.2% (adjusted for currency effec......
Themefolio
Profiler
Peergroup
© BusinessWire
12.02.2025
ICLR
LISTED
NASDAQ
Law Offices of Howard G. Smith Encourages ICON plc (ICLR) Investors To Inquire About Securities Fraud Class Action
News Preview
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased ICON plc (“ICON” or the “Company”) (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”). ICON investors have until April 11, 2025 to file a lead plaintiff motion.
IF YOU ARE...
Themefolio
Profiler
Peergroup
© BusinessWire
12.02.2025
ICLR
LISTED
NASDAQ
ICON SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ICON plc - ICLR
News Preview
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 11, 2025 to file lead plaintiff applications in a securities class action lawsuit against ICON plc (the “Company”) (NasdaqGS: ICLR), if they purchased the Company’s shares between July 27, 2023...
Themefolio
Profiler
Peergroup
© BusinessWire
11.02.2025
ICLR
LISTED
NASDAQ
Rosen Law Firm Urges ICON plc (NASDAQ: ICLR) Stockholders to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of ordinary shares of ICON plc (NASDAQ: ICLR) between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”). ICON is a clinical research organization.
For more information, submit a form, email attorney Philli...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.02.2025
ANAB
LISTED
NASDAQ
Anaptys to Announce Top-line Data from Phase 2b Trial of Rosnilimab, a PD-1 Depleter and Agonist, in Rheumatoid Arthritis on Feb. 12, 2025
News Preview
SAN DIEGO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, will host an investor call and live webcast to review top-line data from the global Phase 2b RENOIR clinical trial of investigational rosnilimab, a depleter and agonist of P...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.02.2025
IBAB
LISTED
EURONEXT
IBA – Transparency Notification
News Preview
...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.02.2025
IBAB
LISTED
EURONEXT
IBA – Transparency Notification IBA SA
News Preview
...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.02.2025
IBAB
LISTED
EURONEXT
IBA - Information réglementée
News Preview
...
Themefolio
Profiler
Peergroup
© BusinessWire
11.02.2025
TEM
LISTED
NASDAQ
Tempus to Report Fourth Quarter and Full Year 2024 Financial Results on February 24
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the fourth quarter and full year 2024 on Monday, February 24, 2025. The company will hold the earnings conference call at 4:30 p.m. ET. The company’s quarterly earnings will be released the same day.
T...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
